Targeting APP/AICD in Down syndrome

por Guidi, Sandra, Stagni, Fiorenza, Bartesaghi, Renata
Publicado 2017

Timing of therapies for Down syndrome: the sooner, the better

por Stagni, Fiorenza, Giacomini, Andrea, Guidi, Sandra, Ciani, Elisabetta, Bartesaghi, Renata
Publicado 2015

The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome

por Stagni, Fiorenza, Uguagliati, Beatrice, Emili, Marco, Giacomini, Andrea, Bartesaghi, Renata, Guidi, Sandra
Publicado 2021

Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone

por Valenti, Daniela, Stagni, Fiorenza, Emili, Marco, Guidi, Sandra, Bartesaghi, Renata, Vacca, Rosa Anna
Publicado 2021

Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome

por Stagni, Fiorenza, Magistretti, Jacopo, Guidi, Sandra, Ciani, Elisabetta, Mangano, Chiara, Calzà, Laura, Bartesaghi, Renata
Publicado 2013

Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse

por Giacomini, Andrea, Stagni, Fiorenza, Emili, Marco, Uguagliati, Beatrice, Rimondini, Roberto, Bartesaghi, Renata, Guidi, Sandra
Publicado 2019

Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome

por Giacomini, Andrea, Stagni, Fiorenza, Trazzi, Stefania, Guidi, Sandra, Emili, Marco, Brigham, Elizabeth, Ciani, Elisabetta, Bartesaghi, Renata
Publicado 2015

Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome

por Stagni, Fiorenza, Raspanti, Alessandra, Giacomini, Andrea, Guidi, Sandra, Emili, Marco, Ciani, Elisabetta, Giuliani, Alessandro, Bighinati, Andrea, Calzà, Laura, Magistretti, Jacopo, Bartesaghi, Renata
Publicado 2017